JPH06165697A - Composition for potassium ion determination - Google Patents

Composition for potassium ion determination

Info

Publication number
JPH06165697A
JPH06165697A JP8961291A JP8961291A JPH06165697A JP H06165697 A JPH06165697 A JP H06165697A JP 8961291 A JP8961291 A JP 8961291A JP 8961291 A JP8961291 A JP 8961291A JP H06165697 A JPH06165697 A JP H06165697A
Authority
JP
Japan
Prior art keywords
potassium ion
composition
present
measurement
glycerol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8961291A
Other languages
Japanese (ja)
Inventor
Yoshihiro Soya
義博 曽家
Shinichi Tejima
真一 手嶋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyobo Co Ltd
Original Assignee
Toyobo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyobo Co Ltd filed Critical Toyobo Co Ltd
Priority to JP8961291A priority Critical patent/JPH06165697A/en
Publication of JPH06165697A publication Critical patent/JPH06165697A/en
Pending legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PURPOSE:To provide a reagent capable of accurately, easily determining in a short time the potassium ions in the body fluid. CONSTITUTION:The objective reagent, a composition containing (A) glycerol dehydrogenase, (B) glycerol and (C) NAD or NADP.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明はカリウムイオン測定用組
成物に関するものである。体液中のカリウムイオン測定
は、急性腎不全や慢性腎不全などの腎疾患、原発性アル
デステロン症や続発性アルデステロン症などの内分泌症
疾患の有用な情報を与えるものとして臨床意義が深い。
FIELD OF THE INVENTION The present invention relates to a composition for measuring potassium ion. The measurement of potassium ion in body fluids is of great clinical significance as it provides useful information on renal diseases such as acute renal failure and chronic renal failure, and endocrine diseases such as primary aldosteronism and secondary aldosteronism.

【0002】[0002]

【従来の技術】従来、金属イオンの測定法としては、炎
光光度計法、化学的測定法、イオン選択電極法が用いら
れていた。しかし炎光光度計法は操作が煩雑であり、試
料の処理能力に問題があった。化学的測定法は操作が煩
雑な上に試薬が高価であるという問題があった。イオン
選択電極法は比較的操作が簡単であるが、電極の劣化が
生じ、試料測定時の測定誤差が問題とされていた。また
最近、酵素を用いる金属イオンの測定法が報告されてい
る(Clin.Chem.35/5 817−82
0)。しかしこの方法は、NADHの紫外部の吸光度の
減少を測定する方法のため、保存中にNADHが減少
し、高値検体の測定ができなくなるという問題があっ
た。
2. Description of the Related Art Conventionally, a flame photometer method, a chemical measuring method, and an ion selective electrode method have been used as a measuring method of metal ions. However, the flame photometer method is complicated in operation and has a problem in sample processing ability. The chemical measurement method has a problem that the operation is complicated and the reagent is expensive. Although the ion-selective electrode method is relatively easy to operate, deterioration of the electrode occurs and measurement error during sample measurement has been a problem. Recently, a method for measuring metal ions using an enzyme has been reported (Clin. Chem. 35/5 817-82.
0). However, since this method is a method of measuring the decrease in the absorbance of NADH in the ultraviolet region, there is a problem in that NADH decreases during storage, making it impossible to measure high-value samples.

【0003】[0003]

【発明が解決しようとする課題】本発明の目的は、上記
現状に鑑み、操作性、定量性、正確性に優れたカリウム
イオンの酵素的測定用組成物を提供することである。
SUMMARY OF THE INVENTION In view of the above situation, an object of the present invention is to provide a composition for enzymatically measuring potassium ion, which is excellent in operability, quantitativeness and accuracy.

【0004】[0004]

【課題を解決するための手段】本発明者らは、上記目的
を達成するために、鋭意検討したところ、グリセロール
デヒドロゲナーゼを利用することにより、体液中のカリ
ウムイオン濃度を短時間に簡単に高感度で正確に測定す
ることを見いだし本発明を完成した。すなわち、本発明
の要旨は、(a)グリセロールデヒドロゲナーゼ、
(b)グリセロールおよび(c)NADまたはNADP
を含有することを特徴とするカリウムイオン測定用組成
物に存する。グリセロールデヒドロゲナーゼを用いる反
応には以下に例示するものが挙げられるが、これは例示
であり何ら本発明の対象を限定するものではない。
[Means for Solving the Problems] The inventors of the present invention have conducted extensive studies to achieve the above-mentioned object. As a result, by utilizing glycerol dehydrogenase, the concentration of potassium ion in body fluid can be easily increased in a short time with high sensitivity. The present invention has been completed by finding accurate measurement with. That is, the gist of the present invention is (a) glycerol dehydrogenase,
(B) Glycerol and (c) NAD or NADP
A composition for measuring potassium ion is characterized by containing: Reactions using glycerol dehydrogenase include those exemplified below, but this is an example and does not limit the subject of the present invention.

【0005】上記の組成物は、下記反応を利用するもの
である。
The above composition utilizes the following reactions.

【化1】 [Chemical 1]

【0006】本発明に用いられるグリセロールデヒドロ
ゲナーゼは特に限定されるものではなく、NADを補酵
素とするもの(EC1.1.1.6)であっても、NA
DPを補酵素とするもの(EC1.1.1.72)であ
ってもよい。
[0006] The glycerol dehydrogenase used in the present invention is not particularly limited, and even if it uses NAD as a coenzyme (EC 1.1.1.6), NA
Those using DP as a coenzyme (EC 1.1.1.72) may be used.

【0007】本発明に用いられるグリセロールデヒドロ
ゲナーゼの起源は特に限定されるものではない。例え
ば、ウサギ骨格筋由来、大腸菌、その他の微生物由来の
ものが用いられ好適にはアエロバクター属、アセトバク
ター属由来のものが使用される。
The origin of the glycerol dehydrogenase used in the present invention is not particularly limited. For example, those derived from rabbit skeletal muscle, Escherichia coli, and other microorganisms are used, and those derived from Aerogenus and Acetobacter are preferably used.

【0008】本発明の試薬のpHは緩衝液によりpH5
〜11に保たれているのが好ましく、緩衝液はカリウム
イオンを含有しないものであれば如何なるものでもよ
い。例えばトリエタノールアミン緩衝液、GOOD緩衝
液、トリス緩衝液が挙げられる。
The pH of the reagent of the present invention depends on the pH of the buffer solution.
It is preferable that the buffer solution is maintained at -11, and the buffer solution may be any as long as it does not contain potassium ions. Examples include triethanolamine buffer, GOOD buffer, and Tris buffer.

【0009】本発明の試薬は必要により、界面活性剤、
防腐剤、さらに安定化剤、酵素賦活剤等を加えてもよ
い。界面活性剤、防腐剤、安定化剤、酵素賦活剤等は特
に限定するものではない。界面活性剤としては、非イオ
ン界面活性剤が好適に用いられる。防腐剤としては、N
aN3 、キレート剤、抗生物質が好適に用いられる。安
定化剤酵素賦活剤としては効果を示すものであれば特に
限定されない。例えば、アルブミン、FAD、マグネシ
ウムイオン等が挙げられる。
If necessary, the reagent of the present invention contains a surfactant,
You may add a preservative, a stabilizer, an enzyme activator, etc. The surfactant, preservative, stabilizer, enzyme activator and the like are not particularly limited. A nonionic surfactant is preferably used as the surfactant. As a preservative, N
AN3, chelating agents and antibiotics are preferably used. The stabilizer enzyme activator is not particularly limited as long as it shows an effect. Examples thereof include albumin, FAD, magnesium ion and the like.

【0010】本発明に用いられるグリセロールデヒドロ
ゲナーゼの測定に使用する酵素濃度は測定に適した濃度
であれば、特に制限されるものではないが、0.01〜
10u/mlの範囲で好適に用いられる。グリセロー
ル、NAD、NADPの測定に使用する濃度としては、
測定に適した濃度であれば特に制限されるものではない
が、グリセロールは、0.001〜5M、NADは、
0.1〜50mM、NADPは、0.1〜1mMの範囲
が好適に用いられる。
The enzyme concentration used for the measurement of glycerol dehydrogenase used in the present invention is not particularly limited as long as it is a concentration suitable for the measurement, but it is from 0.01 to
It is preferably used in the range of 10 u / ml. Concentrations used to measure glycerol, NAD, NADP include:
The concentration is not particularly limited as long as it is a concentration suitable for measurement, but 0.001 to 5 M for glycerol and NAD for
The range of 0.1 to 50 mM and NADP of 0.1 to 1 mM are preferably used.

【0011】本発明のカリウムイオン測定用組成物を用
いて、カリウムイオンを測定する方法は、前記のごとく
試料を、グリセロールデヒドロゲナーゼを含有する該試
薬と反応させて生成するNADH、またはNADPHを
紫外部の吸光度の増加で測定する方法である。本発明の
組成物を用いて測定する条件としては、特に厳密に規制
するものではないが、反応時間は、10〜40度の間
で、37度または、25度が好適に用いられる。反応時
間は、0〜10分の間が好適に用いられる。測定波長と
しては、340nm付近で測定されることが望ましい。
The method for measuring potassium ions using the composition for measuring potassium ions according to the present invention comprises the steps of reacting a sample with the reagent containing glycerol dehydrogenase as described above to generate NADH or NADPH by UV irradiation. It is a method of measuring by the increase of the absorbance. The conditions for measurement using the composition of the present invention are not particularly strictly limited, but the reaction time is preferably 10 to 40 degrees and 37 degrees or 25 degrees. The reaction time is preferably 0 to 10 minutes. It is desirable that the measurement wavelength is around 340 nm.

【0012】[0012]

【実施例】以下、本発明を実施例により詳細に説明す
る。 実施例1 被検体中のカリウムイオン濃度を下記試薬を用いて下記
方法により測定した。 試薬 トリス緩衝液 0.1M (pH9.5) ポリエチレングリコールモノパライソオクチル フェニルエーテル 0.1% NAD 1.0mM グリセロールデヒドロゼナーゼ 70u/1 (Cellulomonas sp.由来)
EXAMPLES The present invention will be described in detail below with reference to examples. Example 1 The potassium ion concentration in a test sample was measured by the following method using the following reagents. Reagent Tris buffer 0.1 M (pH 9.5) Polyethylene glycol monoparaisooctyl phenyl ether 0.1% NAD 1.0 mM Glycerol dehydrogenase 70u / 1 (from Cellulomonas sp.)

【0013】測定方法 塩化カリウム水溶液50mMの10段階希釈液と血清1
0段階希釈液をそれぞれ試料とし、各50μlを採取
し、これに上記試薬3mlを加えて、37℃で10分間
反応させて、340nmにおけるタイムコース(測定波
長において、酵素反応が進んでいる挙動)と1分間の吸
光度変化を求めた。なお、ブランクはカリウムイオン含
有被検液の代わりに蒸留水を用いた。図1に50mMK
Cl水溶液と血清試料のタイムコースを、図2に血清試
料の希釈直線性を、図3に50mMKCl水溶液の希釈
直線性を示す。図より明らかなように、KCl水溶液血
清を試料として用いても、本発明では短時間に正確かつ
簡単にカリウムイオンを測定することができる。
Measurement method 10-step dilution of 50 mM potassium chloride aqueous solution and serum 1
Using the 0-step dilution as a sample, 50 μl of each was sampled, 3 ml of the above reagent was added, and the mixture was allowed to react at 37 ° C. for 10 minutes, followed by a time course at 340 nm (enzymatic reaction progress at the measurement wavelength). And the change in absorbance for 1 minute was determined. In the blank, distilled water was used instead of the potassium ion-containing test liquid. 50 mMK in Figure 1
The time course of the Cl aqueous solution and the serum sample is shown in FIG. 2, and the dilution linearity of the serum sample is shown in FIG. 3, and the dilution linearity of the 50 mM KCl aqueous solution is shown in FIG. As is clear from the figure, even if KCl aqueous solution serum is used as a sample, potassium ions can be measured accurately and easily in a short time in the present invention.

【0014】[0014]

【発明の効果】本発明のカリウムイオン測定用試薬を用
いることにより体液中のカリウムイオンを短時間に正確
かつ簡単に定量することができる。
By using the reagent for measuring potassium ion of the present invention, potassium ion in body fluid can be quantified accurately and easily in a short time.

【図面の簡単な説明】[Brief description of drawings]

【図1】50mMKCl水溶液と血清のタイムコースを
示す。
FIG. 1 shows a time course of 50 mM KCl aqueous solution and serum.

【図2】血清試料の希釈直線性を示す。FIG. 2 shows the dilution linearity of serum samples.

【図3】50mMKCl水溶液の希釈直線性を示す。FIG. 3 shows the dilution linearity of a 50 mM KCl aqueous solution.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 (a)グリセロールデヒドロゲナーゼ、
(b)グリセロールおよび(c)NADまたはNADP
を含有することを特徴とするカリウムイオン測定用組成
物。
1. (a) Glycerol dehydrogenase,
(B) Glycerol and (c) NAD or NADP
A composition for measuring potassium ion, which comprises:
JP8961291A 1991-03-27 1991-03-27 Composition for potassium ion determination Pending JPH06165697A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8961291A JPH06165697A (en) 1991-03-27 1991-03-27 Composition for potassium ion determination

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8961291A JPH06165697A (en) 1991-03-27 1991-03-27 Composition for potassium ion determination

Publications (1)

Publication Number Publication Date
JPH06165697A true JPH06165697A (en) 1994-06-14

Family

ID=13975576

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8961291A Pending JPH06165697A (en) 1991-03-27 1991-03-27 Composition for potassium ion determination

Country Status (1)

Country Link
JP (1) JPH06165697A (en)

Similar Documents

Publication Publication Date Title
JP2610074B2 (en) Method for measuring ions in liquid and composition therefor
Matsubara et al. A spectrophotometric method for the determination of free fatty acid in serum using acyl-coenzyme A synthetase and acyl-coenzyme A oxidase
US5501958A (en) Determination of potassium ions in fluids
JPH0577399B2 (en)
US4120755A (en) Kinetic method for determination of glucose concentrations with glucose dehydrogenase
EP0533183B1 (en) Composition for the measurement of potassium ion concentration
Grossman et al. Simplified, totally enzymatic method for determination of serum triglycerides with a centrifugal analyzer.
US5589348A (en) In situ nicotinamide coenzyme generating system for enzyme based clinical chemistry assays
JPH06165697A (en) Composition for potassium ion determination
CA1060765A (en) Differential assay of creatine phosphokinase isoenzymes
Ogawa et al. A new enzymatic method for the measurement of creatinine involving a novel ATP-dependent enzyme, N-methylhydantoin amidohydrolase
JPH07203991A (en) Quantitative determination of potassium ion
JPH0698031B2 (en) LD-1 isozyme assay and reagents
JPH06311897A (en) Composition for potassium ion measurement
JPH05284996A (en) Method for measuring sodium ion
JPH05176797A (en) Method for determining cholesterol and reagent for determination
IE47123B1 (en) Analytical device
JPH04271799A (en) Method for measuring creatinine by enzyme and its reagent
WO1994023061A1 (en) Method of determining sodium ion
AU662510B2 (en) Determination of ions in fluids
JPH07108239B2 (en) Method for quantifying pyruvic acid and method for quantifying biological components using the method
AU622859B2 (en) Method and composition for the determination of potassium ions in fluids
EP0392021B1 (en) Method for analyzing components
JPH0576394A (en) Composition for potassium ion determination
AU651712B2 (en) Determination of ions in fluids